Eli Lilly appoints Melissa Seymour as executive vice president of Global Quality
Indianapolis: Eli Lilly and Company has announced that Melissa Seymour will join the company as executive vice president of Global Quality and member of the company's Executive Committee, effective 22, 2024.
Seymour currently serves as the chief quality officer for Bristol Myers Squib band succeeds Johna Norton, whose retirement after 34 years of service was announced earlier this year.
"As we expand global capacity to meet demand and support pipeline growth, we remain committed to ensuring our medicines are produced to the highest quality standards," said David A. Ricks, Lilly's chair and CEO. "With more than 25 years of experience and a proven track record of leading strategic quality initiatives across product lifecycles, Melissa will further advance our culture of quality, which has been integral to our success in bringing innovative medicines to people around the world."
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry. She has held senior leadership roles at global pharmaceutical companies, including Bristol Myers Squibb and Biogen, with extended experience at Novo Nordisk and Glaxo Smith Kline. She has led the development of quality compliance strategies, implemented quality processes and systems, and developed talent to ensure the highest level of quality and compliance in the pharmaceutical industry.
Read also: Aktis Oncology
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.